Reuters logo
BRIEF-FDA notifies Seattle Genetics that IND for vadastuximab talirine placed on hold
June 22, 2017 / 10:16 AM / 5 months ago

BRIEF-FDA notifies Seattle Genetics that IND for vadastuximab talirine placed on hold

June 22 (Reuters) - Seattle Genetics Inc:

* Seattle Genetics Inc - fda notified co on June 21, IND for vadastuximab talirine has been placed on hold - SEC filing

* Seattle Genetics Inc - FDA notified co that no clinical trials may resume under IND until FDA lifts clinical hold for vadastuximab talirine Source text: (bit.ly/2rUwjaA) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below